Literature DB >> 34116735

Emodin-induced autophagic cell death hinders epithelial-mesenchymal transition via regulation of BMP-7/TGF-β1 in renal fibrosis.

Wei Liu1, Renze Gu1, Yujiao Lou1, Chunfeng He1, Qingchuan Zhang2, Dongmei Li3.   

Abstract

We aim to explore the effects of emodin and its mechanisms on renal fibrosis (RF). We firstly modeled adriamycin-induced rat RF with unilateral nephrectomy. In vivo and in vitro pharmacological experiments were performed in this study. The presence of collagen deposition was detected by Masson staining. To verify whether emodin attenuates RF by monitoring autophagy, the immunohistochemistry staining for autophagy protein LC3B was performed. We conducted western blot to detect the expression of the autophagy-related proteins in EMT in vitro model after treating with emotin and BMP-7. In vivo, we demonstrated that emodin could improve renal dysfunction and decrease pathological damage of the kidney by activation of autophagy and inhibition of EMT. Upregulation of BMP-7 was recorded in the RF rats subjected to emodin treatment. In vitro studies, emodin has the capacity of reversing EMT and activating autophagy, and emodin could regulate the expression of BMP-7. The results revealed that the attenuation of EMT by emodin could be blocked after the inhibition of BMP-7 and suppression of autophagy. Our findings demonstrated that emodin alleviates EMT during RF by actuating autophagy through BMP-7, suggesting a role of BMP-7 in RF treatment and prevention.
Copyright © 2021 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  1, 3, 8-Trihydroxy-6-methyl anthraquinone; Kidney disease; Pathological mechanism; Renal dysfunction; Treatment

Year:  2021        PMID: 34116735     DOI: 10.1016/j.jphs.2021.03.009

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  4 in total

1.  Network Pharmacology and Experimental Verification Strategies to Illustrate the Mechanism of Jian-Pi-Yi-Shen Formula in Suppressing Epithelial-Mesenchymal Transition.

Authors:  Yuan Zhao; Xiangbin Li; Fochang Wang; Shiying Huang; Hanqian Du; Shunmin Li; Jianping Chen
Journal:  Front Pharmacol       Date:  2022-05-17       Impact factor: 5.988

2.  Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways.

Authors:  Liang-Pu Luo; Ping Suo; Li-Li Ren; Hong-Jiao Liu; Yamei Zhang; Ying-Yong Zhao
Journal:  Front Pharmacol       Date:  2021-12-22       Impact factor: 5.810

Review 3.  Natural products: potential drugs for the treatment of renal fibrosis.

Authors:  Zijun Zhou; Yanheng Qiao; Yanru Zhao; Xin Chen; Jie Li; Hanqing Zhang; Qiumei Lan; Bo Yang
Journal:  Chin Med       Date:  2022-08-17       Impact factor: 4.546

Review 4.  The progress and prospect of natural components in rhubarb (Rheum ribes L.) in the treatment of renal fibrosis.

Authors:  Yangyang Wang; Fangwei Yu; Ao Li; Zijia He; Caiyan Qu; Caiying He; Xiao Ma; Huakui Zhan
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.